Biomarkers of esophageal adenocarcinoma and Barrett's esophagus.
about
NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinomaPrognostic significance of differentially expressed miRNAs in esophageal cancerRole of epigenetic alterations in the pathogenesis of Barrett's esophagus and esophageal adenocarcinomaActivation of Akt is increased in the dysplasia-carcinoma sequence in Barrett's oesophagus and contributes to increased proliferation and inhibition of apoptosis: a histopathological and functional studyComparative proteomic analysis reveals differentially expressed proteins regulated by a potential tumor promoter, BRE, in human esophageal carcinoma cells.Gastroesophageal reflux leads to esophageal cancer in a surgical model with mice.2-methoxyestradiol inhibits Barrett's esophageal adenocarcinoma growth and differentiation through differential regulation of the beta-catenin-E-cadherin axisEsophageal adenocarcinoma: treatment modalities in the era of targeted therapy.TP53 and progression from Barrett's metaplasia to oesophageal adenocarcinoma in a UK population cohortBiomarkers in the molecular pathogenesis of esophageal (Barrett) adenocarcinoma.Hedgehog signaling activation in the development of squamous cell carcinoma and adenocarcinoma of esophagus.Predicting the response of localised oesophageal cancer to neo-adjuvant chemoradiation.Targeting epigenetic regulatory mechanisms in cancer chemoprevention.Increasing expression of hypoxia-inducible proteins in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence.Dietary supplement use and risk of neoplastic progression in esophageal adenocarcinoma: a prospective studyThree-gene immunohistochemical panel adds to clinical staging algorithms to predict prognosis for patients with esophageal adenocarcinoma.Absence of Na+/sugar cotransport activity in Barrett's metaplasiaCigarette smoking, body mass index, gastro-esophageal reflux disease, and non-steroidal anti-inflammatory drug use and risk of subtypes of esophageal and gastric cancers by P53 overexpressionMicroRNA expression signatures in Barrett's esophagus and esophageal adenocarcinoma.Silencing of tumor necrosis factor receptor 1 by siRNA in EC109 cells affects cell proliferation and apoptosis.Chromosomal abnormalities and novel disease-related regions in progression from Barrett's esophagus to esophageal adenocarcinoma.Physical activity, obesity and risk for esophageal adenocarcinoma.Biomarkers in Barrett's oesophagus and oesophageal adenocarcinoma.High resolution integrative analysis reveals widespread genetic and epigenetic changes after chronic in-vitro acid and bile exposure in Barrett's epithelium cells.Whole slide image cytometry: a novel method to detect abnormal DNA content in Barrett's esophagus.Aberrant TP53 detected by combining immunohistochemistry and DNA-FISH improves Barrett's esophagus progression prediction: a prospective follow-up study.Is gastroesophageal reflux disease really a life-long disease: do babies who regurgitate grow up to be adults with GERD complications?Oxidative DNA damage in Barrett mucosa: correlation with telomeric dysfunction and p53 mutation.[Does the criterium of positivity for the immunohistochemical analysis of p53 in the confirmation of Barrett's dysplasia make any difference?].Telomere length and telomerase subunits as diagnostic and prognostic biomarkers in Barrett carcinoma.Molecular Abnormalities in Pediatric Barrett Esophagus: Can We Test for Potential of Neoplastic Progression?
P2860
Q21563424-3A578ACD-AC9C-47F1-AE00-5D99BCB7EFF9Q24612881-85ED1B99-D6F4-42D8-9375-7E8B096D95BAQ24632246-0CFE8503-CA9B-41C2-9458-62A38A29C7BBQ33287238-7478B864-61D7-4B7E-BCF7-4A62290E0C89Q33364727-D3A85260-A762-4A01-9C1E-052A425F414EQ33486164-9C98189C-8D5C-4D7B-90AD-52DB4591E8DFQ33723517-80BAE584-137E-48F6-98A8-CBD9A1EFBE8FQ33932460-FC578D34-E8D3-4072-A896-F79679FCCB9EQ35760858-9C59F93B-E819-441C-BAE4-209CCF8299A0Q35840327-E89D0DF7-5C9A-446D-A316-ECDE8D73F807Q35887469-20215EA1-82DC-4B20-808A-4056135FA4C7Q36022348-4684D2AE-A3B4-4A89-8C45-36893D8ACF62Q36150848-09D6CA5C-6E31-4712-BE08-01ED9B535A61Q36610386-A300A40B-CA63-4690-9CC2-16726626CC11Q36629369-82D6C609-F356-42B2-92F9-84B937AC48B2Q36763844-1BBA83E4-12C1-4099-992A-35DA7B4E5EABQ37220658-9663BD83-3CA6-49BE-B30F-4B3649D70BE2Q37305467-FB9ECB46-FA01-4DCF-B4F3-8FF06125F06EQ37350288-10C8E390-53FA-48A8-8183-8FFC03AF8C42Q37383643-B7380297-3750-4805-8452-3E019FFD53EAQ37398079-4AD7E8C1-3FF6-4321-B438-0548E045B46FQ37605867-BBA8C8AA-434F-417D-9EE9-07B135E4F6E0Q38089259-C4B2C8EF-B192-4048-86DF-60DDEC0A2012Q38484630-B951AB5D-D847-4488-A088-B32250941FC4Q38559655-91D35E9D-ADF2-43E2-8EC2-7D29866A8758Q38950372-8F82DCF2-854D-4815-B93B-357C46702249Q42492209-5E8DFEB7-DBAA-4E29-8090-610A820A22E2Q44769510-5AA93074-5EC0-477A-9A37-3E535454BA0DQ50481425-22BDE9B5-BC71-44D3-A916-C2BE45AF381AQ54541663-5DE72634-662A-4C2F-8B83-623339C47114Q57828317-52A6CDCD-225F-49E3-AE6F-AB0FEE32497B
P2860
Biomarkers of esophageal adenocarcinoma and Barrett's esophagus.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Biomarkers of esophageal adenocarcinoma and Barrett's esophagus.
@ast
Biomarkers of esophageal adenocarcinoma and Barrett's esophagus.
@en
type
label
Biomarkers of esophageal adenocarcinoma and Barrett's esophagus.
@ast
Biomarkers of esophageal adenocarcinoma and Barrett's esophagus.
@en
prefLabel
Biomarkers of esophageal adenocarcinoma and Barrett's esophagus.
@ast
Biomarkers of esophageal adenocarcinoma and Barrett's esophagus.
@en
P2093
P1433
P1476
Biomarkers of esophageal adenocarcinoma and Barrett's esophagus.
@en
P2093
Andreea Olaru
Damian T McManus
Stephen J Meltzer
P304
P356
10.1158/0008-5472.CAN-03-2438
P407
P577
2004-03-01T00:00:00Z